1. Home
  2. TIL vs OGI Comparison

TIL vs OGI Comparison

Compare TIL & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • OGI
  • Stock Information
  • Founded
  • TIL 2018
  • OGI 2013
  • Country
  • TIL United States
  • OGI Canada
  • Employees
  • TIL N/A
  • OGI N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • OGI Biotechnology: Pharmaceutical Preparations
  • Sector
  • TIL Health Care
  • OGI Health Care
  • Exchange
  • TIL Nasdaq
  • OGI Nasdaq
  • Market Cap
  • TIL 170.7M
  • OGI 165.0M
  • IPO Year
  • TIL 2021
  • OGI N/A
  • Fundamental
  • Price
  • TIL $21.17
  • OGI $1.59
  • Analyst Decision
  • TIL Buy
  • OGI
  • Analyst Count
  • TIL 4
  • OGI 0
  • Target Price
  • TIL $100.33
  • OGI N/A
  • AVG Volume (30 Days)
  • TIL 107.5K
  • OGI 726.1K
  • Earning Date
  • TIL 11-13-2024
  • OGI 02-11-2025
  • Dividend Yield
  • TIL N/A
  • OGI N/A
  • EPS Growth
  • TIL N/A
  • OGI N/A
  • EPS
  • TIL N/A
  • OGI N/A
  • Revenue
  • TIL N/A
  • OGI $110,297,722.00
  • Revenue This Year
  • TIL N/A
  • OGI $8.76
  • Revenue Next Year
  • TIL $2.65
  • OGI $14.04
  • P/E Ratio
  • TIL N/A
  • OGI N/A
  • Revenue Growth
  • TIL N/A
  • OGI 2.33
  • 52 Week Low
  • TIL $6.72
  • OGI $1.21
  • 52 Week High
  • TIL $92.00
  • OGI $2.91
  • Technical
  • Relative Strength Index (RSI)
  • TIL 36.47
  • OGI 57.86
  • Support Level
  • TIL $20.57
  • OGI $1.45
  • Resistance Level
  • TIL $22.69
  • OGI $1.73
  • Average True Range (ATR)
  • TIL 2.72
  • OGI 0.10
  • MACD
  • TIL -0.23
  • OGI 0.02
  • Stochastic Oscillator
  • TIL 2.98
  • OGI 74.19

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About OGI Organigram Holdings Inc.

OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.

Share on Social Networks: